Cargando…

NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models

Parkinson’s disease (PD) is mainly characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and neuroinflammation mediated by overactivated microglia and astrocytes. NLRC5 (nucleotide-binding oligomerization domain-like receptor family caspas...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhaolin, Shen, Chenye, Li, Heng, Tong, Jiabin, Wu, Yufei, Ma, Yuanyuan, Wang, Jinghui, Wang, Zishan, Li, Qing, Zhang, Xiaoshuang, Dong, Hongtian, Yang, Yufang, Yu, Mei, Wang, Jian, Zhou, Renyuan, Fei, Jian, Huang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111753/
https://www.ncbi.nlm.nih.gov/pubmed/37072793
http://dx.doi.org/10.1186/s12974-023-02755-4
_version_ 1785027511703306240
author Liu, Zhaolin
Shen, Chenye
Li, Heng
Tong, Jiabin
Wu, Yufei
Ma, Yuanyuan
Wang, Jinghui
Wang, Zishan
Li, Qing
Zhang, Xiaoshuang
Dong, Hongtian
Yang, Yufang
Yu, Mei
Wang, Jian
Zhou, Renyuan
Fei, Jian
Huang, Fang
author_facet Liu, Zhaolin
Shen, Chenye
Li, Heng
Tong, Jiabin
Wu, Yufei
Ma, Yuanyuan
Wang, Jinghui
Wang, Zishan
Li, Qing
Zhang, Xiaoshuang
Dong, Hongtian
Yang, Yufang
Yu, Mei
Wang, Jian
Zhou, Renyuan
Fei, Jian
Huang, Fang
author_sort Liu, Zhaolin
collection PubMed
description Parkinson’s disease (PD) is mainly characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and neuroinflammation mediated by overactivated microglia and astrocytes. NLRC5 (nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing 5) has been reported to participate in various immune disorders, but its role in neurodegenerative diseases remains unclear. In the current study, we found that the expression of NLRC5 was increased in the nigrostriatal axis of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced PD, as well as in primary astrocytes, microglia and neurons exposed to different neurotoxic stimuli. In an acute MPTP-induced PD model, NLRC5 deficiency significantly reduced dopaminergic system degeneration and ameliorated motor deficits and striatal inflammation. Furthermore, we found that NLRC5 deficiency decreased the expression of the proinflammatory genes IL-1β, IL-6, TNF-α and COX2 in primary microglia and primary astrocytes treated with neuroinflammatory stimuli and reduced the inflammatory response in mixed glial cells in response to LPS treatment. Moreover, NLRC5 deficiency suppressed activation of the NF-κB and MAPK signaling pathways and enhanced the activation of AKT–GSK-3β and AMPK signaling in mixed glial cells. Furthermore, NLRC5 deficiency increased the survival of primary neurons treated with MPP(+) or conditioned medium from LPS-stimulated mixed glial cells and promoted activation of the NF-κB and AKT signaling pathways. Moreover, the mRNA expression of NLRC5 was decreased in the blood of PD patients compared to healthy subjects. Therefore, we suggest that NLRC5 promotes neuroinflammation and dopaminergic degeneration in PD and may serve as a marker of glial activation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02755-4.
format Online
Article
Text
id pubmed-10111753
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101117532023-04-19 NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models Liu, Zhaolin Shen, Chenye Li, Heng Tong, Jiabin Wu, Yufei Ma, Yuanyuan Wang, Jinghui Wang, Zishan Li, Qing Zhang, Xiaoshuang Dong, Hongtian Yang, Yufang Yu, Mei Wang, Jian Zhou, Renyuan Fei, Jian Huang, Fang J Neuroinflammation Research Parkinson’s disease (PD) is mainly characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and neuroinflammation mediated by overactivated microglia and astrocytes. NLRC5 (nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing 5) has been reported to participate in various immune disorders, but its role in neurodegenerative diseases remains unclear. In the current study, we found that the expression of NLRC5 was increased in the nigrostriatal axis of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced PD, as well as in primary astrocytes, microglia and neurons exposed to different neurotoxic stimuli. In an acute MPTP-induced PD model, NLRC5 deficiency significantly reduced dopaminergic system degeneration and ameliorated motor deficits and striatal inflammation. Furthermore, we found that NLRC5 deficiency decreased the expression of the proinflammatory genes IL-1β, IL-6, TNF-α and COX2 in primary microglia and primary astrocytes treated with neuroinflammatory stimuli and reduced the inflammatory response in mixed glial cells in response to LPS treatment. Moreover, NLRC5 deficiency suppressed activation of the NF-κB and MAPK signaling pathways and enhanced the activation of AKT–GSK-3β and AMPK signaling in mixed glial cells. Furthermore, NLRC5 deficiency increased the survival of primary neurons treated with MPP(+) or conditioned medium from LPS-stimulated mixed glial cells and promoted activation of the NF-κB and AKT signaling pathways. Moreover, the mRNA expression of NLRC5 was decreased in the blood of PD patients compared to healthy subjects. Therefore, we suggest that NLRC5 promotes neuroinflammation and dopaminergic degeneration in PD and may serve as a marker of glial activation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-023-02755-4. BioMed Central 2023-04-18 /pmc/articles/PMC10111753/ /pubmed/37072793 http://dx.doi.org/10.1186/s12974-023-02755-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Zhaolin
Shen, Chenye
Li, Heng
Tong, Jiabin
Wu, Yufei
Ma, Yuanyuan
Wang, Jinghui
Wang, Zishan
Li, Qing
Zhang, Xiaoshuang
Dong, Hongtian
Yang, Yufang
Yu, Mei
Wang, Jian
Zhou, Renyuan
Fei, Jian
Huang, Fang
NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title_full NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title_fullStr NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title_full_unstemmed NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title_short NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson’s disease models
title_sort nod-like receptor nlrc5 promotes neuroinflammation and inhibits neuronal survival in parkinson’s disease models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111753/
https://www.ncbi.nlm.nih.gov/pubmed/37072793
http://dx.doi.org/10.1186/s12974-023-02755-4
work_keys_str_mv AT liuzhaolin nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT shenchenye nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT liheng nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT tongjiabin nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT wuyufei nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT mayuanyuan nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT wangjinghui nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT wangzishan nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT liqing nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT zhangxiaoshuang nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT donghongtian nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT yangyufang nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT yumei nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT wangjian nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT zhourenyuan nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT feijian nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels
AT huangfang nodlikereceptornlrc5promotesneuroinflammationandinhibitsneuronalsurvivalinparkinsonsdiseasemodels